Increased investment market exposure to complement immediate and long- term financing objectives
TORONTO, ONTARIO – CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”), a global medical provider of consumer heart monitoring and medical electrocardiogram (“ECG”) software solutions, today announced that it has engaged the services of FronTier Merchant Capital Group (“FronTier”) to provide it with investor relations services.
FronTier is a highly experienced and recognized investor relations group, headquartered in Toronto with additional offices and IR reps across Canada and the USA. FronTier will assist the Company in increasing market awareness by facilitating corporate introductions between CardioComm Solutions and institutional brokers and investors, as well as by engaging the industry’s best retail marketing firms to assist the Company.
Under the terms of the engagement, FronTier has been retained for a fee of $6,250 (plus HST) per month. CardioComm Solutions has also issued 300,000 incentive stock options to FronTier at an exercise price of $0.075, vesting in equal quarterly installments over 12 months and expiring five years from the date of grant. FronTier and its related companies currently own a total of 2,700,000 common shares of the Company.
By engaging FronTier, the Company seeks to increase CardioComm Solutions’ awareness within the institutional investor marketplace over the next several quarters, both in Canada and the US.
FronTier’s engagement coincides with the Company’s announcement of its best three-quarter fiscal performance in 17 years. The Company also continues to address its immediate priority to retire an outstanding debt of $900,000 that is due at the end of December 2016. CardioComm Solutions will also seek to structure follow-up financing through institutional investments for use in increasing sales of CardioComm Solutions’ consumer and medical ECG management software technologies. In addition, these funds will be used to quicken medical device marketing submissions for the Company’s developing portfolio of handheld and wearable ECG monitoring devices and fee-for-service SMART Monitoring ECG services.
To learn more about CardioComm Solutions please see the Company’s websiteswww.theheartcheck.com and www.cardiocommsolutions.com or contact the Company at sales@cardiocommsolutions.com.
